The global hormonal contraceptive market was valued at $17.3 billion in 2023, and is projected to reach $26.6 billion by 2035, growing at a CAGR of 3.6% from 2024 to 2035.
Report Code : A04222 | Pages : 348 | Category : Life Sciences
The global cannabinoid based drug discovery and development market was valued at $1.3 billion in 2024, and is projected to reach $1.8 billion by 2034, growing at a CAGR of 3.3% from 2025 to 2034.
Report Code : A325539 | Pages : 272 | Category : Life Sciences
The global aspirin drugs market was valued at $1.3 billion in 2023, and is projected to reach $1.8 billion by 2035, growing at a CAGR of 2.7% from 2024 to 2035.
Report Code : A325604 | Pages : 264 | Category : Life Sciences
The erythropoietin drugs market size was valued at $9,243.12 million in 2020, and is projected to reach $14,414.59 million by 2028, registering a CAGR of 5.7% from 2021 to 2028.
Report Code : A00001 | Pages : 165 | Category : Life Sciences
The global protein therapeutics market size was valued at $283.64 Billion in 2020, and is estimated to reach $566.66 Billion by 2030, growing at a CAGR of 7.1% ...
Report Code : A00002 | Pages : 211 | Category : Life Sciences
Secure packaging is one of the essential techniques to avoid counterfeiting. Anti counterfeit packaging is defined as the process of assigning secure packaging to the product in order ...
Report Code : A00029 | Pages : 341 | Category : Life Sciences
The global oncology-cancer drugs market was valued at $167.0 billion in 2023, and is projected to reach $335.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.
Report Code : A00042 | Pages : 250 | Category : Life Sciences
The global global therapeutic vaccines market was valued at $26.7 billion in 2023, and is projected to reach $135.7 billion by 2033, growing at a CAGR of 19.1% from 2024 to 2033.
Report Code : A00074 | Pages : 300 | Category : Life Sciences
The global point of care diagnostics market was valued at $29,478.63 million in 2020 and is projected to reach $55,275.73 million by 2030, growing at a CAGR of 6.5% from 2021 to 2030.
Report Code : A00080 | Pages : 215 | Category : Life Sciences
The global biosimilars market was valued at $15.9 billion in 2021, and is projected to reach $143.6 billion by 2031, growing at a CAGR of 24.7% from 2022 to 2031.
Report Code : A00573 | Pages : 242 | Category : Life Sciences
The global Asthma and COPD Drugs Market Size was valued at $32988.7 million in 2020 and is projected to reach $52049.54 million by 2030, registering a CAGR of 4.64% from 2021 to 2030.
Report Code : A00221 | Pages : 120 | Category : Life Sciences
The global ovarian cancer drugs market was valued at $2.3 billion in 2021, and is projected to reach $5.1 billion by 2031, growing at a CAGR of 8.4% from 2022 to 2031.
Report Code : A00273 | Pages : 189 | Category : Life Sciences
The global orphan drugs market size was valued at $1,40,000.0 million in 2020 and is projected to reach $4,35,686.3 million by 2030 registering a CAGR of 11.8% from ...
Report Code : A00116 | Pages : 356 | Category : Life Sciences
The global non-alcoholic steatohepatitis (NASH) market generated $1,179 million in 2017, and is projected to reach $21,478 million by 2025, growing at a CAGR of 58.4% from 2021 ...
Report Code : A00135 | Pages : 155 | Category : Life Sciences
The global vaccines market was valued at $43.2 billion in 2023, and is projected to reach $90.7 billion by 2035, growing at a CAGR of 6.4% from 2024 to 2035.
Report Code : A00168 | Pages : 350 | Category : Life Sciences
The global anti-inflammatory therapeutics market size was $98,026 million in 2020 and is projected to reach $125,552 million by 2028, registering a CAGR of 4.0% from 2021 to 2028
Report Code : A00196 | Pages : 190 | Category : Life Sciences
The global ophthalmic drugs market generated $36,488.48 million in 2019, and is projected to reach $58,134.92 million by 2027, growing at a CAGR of 5.6% from 2020 to ...
Report Code : A00220 | Pages : 564 | Category : Life Sciences
The global antiepileptic drugs market was valued at $16.8 billion in 2023, and is projected to reach $27.5 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.
Report Code : A00356 | Pages : 280 | Category : Life Sciences
The global incretin-based drugs market was valued at $34.4 billion in 2022, and is projected to reach $73.9 billion by 2032, growing at a CAGR of 7.9% from 2023 to 2032.
Report Code : A00535 | Pages : 250 | Category : Life Sciences
The global ivf services market was valued at $19.6 billion in 2023, and is projected to reach $47.9 Billion by 2033, growing at a CAGR of 9.3% from 2024 to 2033
Report Code : A00556 | Pages : 260 | Category : Life Sciences
The global intravenous immunoglobulin market was valued at $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 ...
Report Code : A00235 | Pages : 202 | Category : Life Sciences
The global pharmaceutical packaging equipment market was valued at $7.6 billion in 2022, and is projected to reach $15.2 billion by 2032, growing at a CAGR of 7.1% from 2023 to 2032.
Report Code : A00283 | Pages : 395 | Category : Life Sciences
The global liver disease treatment market size was valued at $20,673.70 million in 2020, and is estimated to reach $36,455.70 million by 2030, growing at a CAGR of ...
Report Code : A00295 | Pages : 254 | Category : Life Sciences
The global regenerative medicine market was valued at $32.1 billion in 2023, and is projected to reach $531.7 Billion by 2033, growing at a CAGR of 32.4% from 2024 to 2033
Report Code : A00298 | Pages : 216 | Category : Life Sciences
The global pain management drugs market was valued at $72.6 billion in 2023, and is projected to reach $109.6 Billion by 2033, growing at a CAGR of 4.2% from 2024 to 2033
Report Code : A00309 | Pages : 216 | Category : Life Sciences
